HO-1 and HO-2 are the products of two distinct genes, which are located in chromosome 22 for HO-1 and chromosome 16 for HO-2, respectively
Current clinical practice considerations emphasize the importance of ophthalmologic screening before initiating GLP-1 therapy in patients with longstanding diabetes and implementing more gradual titration schedules in those with known retinal disease to minimize the risk of early worsening
Mcelroy SL, Guerdjikova AI, Blom TJ, Mori N, Romo-Nava F
If these side effects occur, healthcare providers may: Adjust the dosage
Traditionally, generic medications tend to cost less and may be easier to access through insurance, though that isnt always guaranteed
REWIND, Researching cardiovascular Events with a Weekly Incretin in Diabetes